The funds will be used to further invest in its product innovation, including its Polaris Safety Constellation Architecture, and to merge with or purchase other companies.

The company will use the funds to expand its in-house operations in New York and San Diego, as well as accelerate the trials and commercialization of its BCI.

Government regulation can slow health systems' AI progress; Ed Marx, Marx Advisory CEO, says showing policymakers AI's real-world benefits in person can help them understand its value more than traditional lobbying.

At Future of Health’s invitation-only event, former CDC Director Dr. Rochelle Walensky sat down with MobiHealthNews to discuss the potential and challenges of AI in healthcare.

Lisa Suennen, managing partner at American Heart Association Ventures, and Ruby Gadelrab, CEO and founder of MDisrupt, explores next steps after AHA's $1 million milestone investment into MDisrupt, including plans to co-develop a platform.

Trained on 500,000 pathology slides, the AI predicts cancer type, treatment response, and survival with over 95% accuracy within minutes.